SCHISTOCYTOSIS

This adverse event was reported 87 times

These drugs are most commonly taken by patients reporting SCHISTOCYTOSIS:

# Drug Count
0 ECULIZUMAB 13
1 TACROLIMUS 13
2 TACROLIMUS EXTENDED-RELEASE CAPSULES 13
3 TACROLIMUS OINTMENT 0.1% 13
4 ETOPOSIDE 11
5 RITUXIMAB 11
6 MELPHALAN HYDROCHLORIDE 10
7 METHOTREXATE SODIUM 10
8 PREDNISONE 10
9 MELPHALAN 9
See all common drugs associated with SCHISTOCYTOSIS

SCHISTOCYTOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PLERIXAFOR 5 0.0034
1 ONASEMNOGENE ABEPARVOVEC-XIOI 4 0.0017
2 GRANULOCYTE COLONY STIMULATING FACTOR 2 0.0009
3 CAPLACIZUMAB 1 0.0006
4 BENDAMUSTINE HYDROCHLORIDE 4 0.0005
5 MELPHALAN HYDROCHLORIDE 10 0.0004
6 VANCOMYCIN HYDROCHLORIDE 2 0.0002
7 ECULIZUMAB 13 0.0002
8 CAPTOPRIL 2 0.0002
9 PONATINIB HYDROCHLORIDE 1 0.0002
See all drugs enriched for association with SCHISTOCYTOSIS